INCIDENCE AND PATTERNS OF NEONATAL JAUNDICE IN TERTIARY MEDICAL FACILITY
Main Article Content
Keywords
Neonatal Jaundice, Total serum bilirubin, Interventions, Hyperbilirubinemia, Phototherapy, Prematurity
Abstract
Neonatal jaundice is yellowish discoloration of white part of eyes and skin of an infant because of elevated bilirubin level due to the difference between production and excretion of bilirubin. The jaundice frequently appears between 1-3 days of life following delivery in 60% of term and 80% preterm babies and disappears in 10-14 days which sometime required interventions. The study was aimed to assess the prevalence of neonatal jaundice and risk factors in a tertiary care hospital Lahore, Pakistan. It is important to understand and acknowledge how different risk factor causes hyperbilirubinemia in neonates. A total of 366 newborns were enrolled in this study. A questionnaire was filled with necessary information about newborns demographic parameters, blood group and serum bilirubin level. The data were analyzed by SPSS version 25. The total serum bilirubin was found up to >40 mg dL-1 in both gender. 53.5% neonates develop jaundice due to unknown causes. It was concluded that the main reason of neonatal jaundice was ABO and Rh incompatibility between mother and neonates. Phototherapy and immunoglobulin’s were the effective ways of treating the neonatal jaundice. Low birth weight, prematurity and gender of neonates were not the risk factors.
References
2. Thomas M, Greaves RF, Tingay DG, Loh TP, Ignjatovic V, Newall F, Oeum M, Tran MT, Rajapaksa AE. Current and emerging technologies for the timely screening and diagnosis of neonatal jaundice. Critical Reviews in Clinical Laboratory Sciences. 2022;59(5):332-52.
3. Anne RP, Rahiman EA, Dudeja S, Kumar A. Diagnostic accuracy of cord bilirubin to predict the need for phototherapy in healthy neonates> 35-weekágestational age: a systematic review and meta-analysis. Journal of Clinical and Experimental Hepatology. 2023;13(4):666-81.
4. Arya N. A state of the art review on jaundice disease. Academicia: An International Multidisciplinary Research Journal. 2021;11(11):765-71.
5. Boskabadi H, Sezavar M, Zakerihamidi M. Evaluation of neonatal jaundice based on the severity of hyperbilirubinemia. Journal of Clinical Neonatology. 2020;9(1):46-51.
6. Moghadam MB, Esmaeili M, Khosravan S, Mojtabavi SJ. Effects of foot reflexology on neonatal jaundice: A randomized sham-controlled trial. European Journal of Integrative Medicine. 2020;38:101173.
7. Jackson ME, Baker JM. Hemolytic disease of the fetus and newborn: historical and current state. Clinics in Laboratory Medicine. 2021;41(1):133-51.
8. Banerjee A, Bhattacharyya N, Ghosh R, Singh S, Adhikari A, Mondal S, Roy L, Bajaj A, Ghosh N, Bhushan A, Goswami M. Non-invasive estimation of hemoglobin, bilirubin and oxygen saturation of neonates simultaneously using whole optical spectrum analysis at point of care. Scientific Reports. 2023;13(1):2370.
9. Marzoog AS, Mohammed HN, Habib KD. Effectiveness of conventional phototherapy, intensive phototherapy and exchange transfusion in treating neonatal jaundice at Fatima Al-Zahra Hospital for maternity and children in Baghdad. Al-Kindy College Medical Journal. 2020;16(2):25-9.
10. Deb J, Jain A, Kaur D, Bahadur A, Basu S, Negi G. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO hemolytic disease of newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India. Transfusion and Apheresis Science. 2023;13:103864.
11. Agrawal A, Hussain KS, Kumar A. Minor blood group incompatibility due to blood groups other than Rh (D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy. Intractable & Rare Diseases Research. 2020;9(1):43-7.
12. Yan H, Zhou Q, Zhu H, Yang H, Wang H, Ling J, et al. Effects of Tuina on newborns with jaundice: A meta-analysis. Medicine. 2022;101(29).
13. Guo Q, Cui M, Liu X, Zhao S, Liu P, Wang L. Effect of epidermal growth factor in human Milk and maternal diet on late-onset breast milk jaundice: a case-control study in Beijing. Nutrients. 2022;14(21):4587.
14. Wan Mohd Hanafi WS, Wan Ibrahim WN, Hashim N. Factors associated with exchange transfusion among severe neonatal jaundice in Malaysia. Iranian Journal of Neonatology. 2021;12(3).
15. Singh S, Tripathi S, Kumar M, Bhreguvanshi A, Chandra T. Serum bilirubin trend, hematological and clinical profile of late preterm and term neonates with unconjugated hyperbilirubinemia-A prospective observational study. Clinical Epidemiology and Global Health. 2021;10:100680.
16. Ravali V, Kumar GJ, Shailendra B, Krishna S, Sudheer D, and Kishore K. Incidence and prevalence of infectious and non infectious diseases in paediatric patients in Warangal region. 2019;8(8):352-356.
17. Abiti H, Dedefo A, Lemma L. prevalence and associated factors of hyperbilirubinemia among neonates admitted to neonatal intensive care unit of Saint Peter Specialized Hospital, Addis Ababa, Ethiopia. Science. 2023;11(3):56-63.
18. Siyal AA, Shah J, Taqi T, Haider S. Hyperbilirubinemia: Prevalence of hyperbilirubinemia and causative factors in neonates admitted in neonatal unit pediatric ward Nawabshah. The Professional Medical Journal. 2019;26(01):128-31.
19. Thakur AK, Ansari MA, Mishra A, Jha SK. Outcome of neonatal jaundice in term neonates with ABO incompatibility at tertiary level center. International Journal of Contemporary Pediatrics. 2020;7(10):1973-7.
20. Harsha GN. Prevalence of neonatal jaundice in a maternity home nternational Journal of Academic Medicine and Pharmacy. 2023;5(5):1184-8.
21. Bizuneh AD, Alemnew B, Getie A, Wondmieneh A, Gedefaw G. Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study. BMJ Paediatrics Open. 2020;4(1): e000830.
22. Okulu E, Erdeve O, Kilic I, Olukman O, Calkavur S, Buyukkale G, et al. Intravenous immunoglobulin use in hemolytic disease due to ABO incompatibility to prevent exchange transfusion. Frontiers in Pediatrics. 2022;10:864609.
23. El Fekey SWI, El-Sharkawy HM, Ahmed AA-EE, Nassar MA-E, Elgendy MM. Effect of intravenous immunoglobulin in reducing bilirubin levels in hemolytic disease of newborn. The Egyptian Journal of Hospital Medicine. 2019;74(5):957-68.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Muhammad Waseem Ashraf
University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Pakistan
Iqra Munir
University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Pakistan.
Nosheen Munir
Institute of Dentistry, CMH, Lahore, Pakistan.
Kainat Waheed
University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Pakistan
Bushra Mubarak
Department of Medical Laboratory Technology, Dr. Ikram-ul-Haq Institute of Industrial Biotechnology, Government College University, Lahore, Pakistan
Sumaira Kausar
University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Pakistan
Saher Mehmood
Department of Microbiology and Molecular Genetics, The Women University Multan, Pakistan
Sara Junaid
Department of Microbiology and Molecular Genetics, The Women University Multan, Pakistan
Hira Muzammal
School of Medical Lab Technology, Minhaj University Lahore, Pakistan